News

Filter

US FDA backs news indications for Latuda; grants Priority Review for Perjeta

02-07-2013

Sunovion Pharmaceuticals, a US subsidiary of Japan's Dainippon Sumitomo Pharma (TYO: 4506), says that…

BiotechnologyDainippon Sumitomo PharmaLatudaNeurologicalNorth AmericaOncologyPerjetaPharmaceuticalRegulationRocheSunovion

Dainippon Sumitomo files for approval of Calsed in China

06-09-2012

Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) has submitted an imported drug registration…

Asia-PacificCalsedDainippon Sumitomo PharmaOncologyPharmaceuticalRegulation

Dainippon Sumitomo to set up DSP Cancer Institute

21-08-2012

Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) says it plans to establish a new organization…

BiotechnologyDainippon Sumitomo PharmaManagementOncologyPharmaceuticalResearch

Dainippon Sumitomo licenses cancer drug from Boston Biomedical for up to $100 million

08-04-2011

In a fourth product rights acquisition in a matter of two weeks, Dainippon Sumitomo Pharma (4506: JP)…

Boston BiomedicalDainippon Sumitomo PharmaLicensingOncologyPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top